Top 10 Holdings
Summary by AI BETAClose X
JPMorgan Claverhouse Investment Trust PLC has disclosed its ten largest investments as a percentage of total assets as of September 30, 2026, with HSBC Holdings Plc representing 9.2% and Shell Plc at 7.8%. Other significant holdings include AstraZeneca Group Plc and Rolls-Royce Plc, each at 4.7%, followed by Natwest Group Plc at 4.5%. British American Tobacco Plc accounts for 3.4%, while Glencore Plc and GSK Plc each represent 3.0%. Barclays Plc and BP Plc round out the top ten, with each holding 2.8%. Collectively, these top ten investments comprise 45.9% of the Company's total assets, excluding liquidity stocks.
JPMorgan Claverhouse IT PLC
14 October 2026
|
JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC (the 'Company') |
|
|
Legal Entity Identifier: 549300NFZYYFSCD52W53 |
|
|
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 30 September 2026 |
|
|
Hsbc Holdings Plc |
9.2% |
|
Shell Plc |
7.8% |
|
Astrazeneca Group Plc |
4.7% |
|
Rolls-Royce Plc |
4.7% |
|
Natwest Group Plc |
4.5% |
|
British American Tobacco Plc |
3.4% |
|
Glencore Plc |
3.0% |
|
Gsk Plc |
3.0% |
|
Barclays Plc |
2.8% |
|
Bp Plc |
2.8% |
|
Total |
45.9% |
|
Excludes Investments in Liquidity stocks |
|
|
Name of contact and telephone number for queries: |
|
|
Paul Ainger 0044 207 742 6524 |
|
|
Name of authorised company official responsible for making this notification: |
|
|
Anmol Dhillon 020 7742 4000 - Company Secretary |
|
|
Date: 14 October 2026 |
|
|
|
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 1 day ago Tesco
- 1 day ago Dr. Martens
- 1 day ago YouGov
- 1 day ago Vistry Group
- 1 day ago Cohort